These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25540021)
1. A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases. Neuwirt H; Perco P; Kainz A; Mühlberger I; Leierer J; Braniff SJ; Mayer B; Mayer G; Rudnicki M BMC Med Genomics; 2014 Dec; 7():75. PubMed ID: 25540021 [TBL] [Abstract][Full Text] [Related]
2. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis. Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Rudnicki M; Eder S; Perco P; Enrich J; Scheiber K; Koppelstätter C; Schratzberger G; Mayer B; Oberbauer R; Meyer TW; Mayer G Kidney Int; 2007 Feb; 71(4):325-35. PubMed ID: 17183245 [TBL] [Abstract][Full Text] [Related]
4. Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease. Rossi G; Giordano A; Breda S; Lisi C; Roura X; Zatelli A; Paltrinieri S Vet J; 2013 Oct; 198(1):109-15. PubMed ID: 23899407 [TBL] [Abstract][Full Text] [Related]
5. Increased renal versican expression is associated with progression of chronic kidney disease. Rudnicki M; Perco P; Neuwirt H; Noppert SJ; Leierer J; Sunzenauer J; Eder S; Zoja C; Eller K; Rosenkranz AR; Müller GA; Mayer B; Mayer G PLoS One; 2012; 7(9):e44891. PubMed ID: 23024773 [TBL] [Abstract][Full Text] [Related]
6. The predictive value of urinary vascular endothelial growth factor (VEGF) on worsening kidney function in proteinuric chronic kidney disease. Avguštin N; Rotar Ž; Pajek J; Kovač D; Osredkar J; Lindič J Clin Nephrol; 2017 Supplement 1; 88(13):10-13. PubMed ID: 28601119 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-7 and disease progression in renal amyloidosis patients. Denizli N; Azak A; Şakacı M; Huddam B; Koçak G; Akdoğan MF; Demirci R; Gücün M; Ortabozkoyun L; Fidan Y; Akdağ İ; Duranay M Ren Fail; 2013 Sep; 35(8):1112-5. PubMed ID: 23902471 [TBL] [Abstract][Full Text] [Related]
8. A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study. Zhang T; Chen H; Liang S; Chen D; Zheng C; Zeng C; Zhang H; Liu Z PLoS One; 2014; 9(11):e111992. PubMed ID: 25372665 [TBL] [Abstract][Full Text] [Related]
9. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844 [TBL] [Abstract][Full Text] [Related]
10. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821 [TBL] [Abstract][Full Text] [Related]